ECOR - エレクトロコア （electroCore Inc.）

https://www.investing.com/news/assorted/electrocore-announces-departure-of-jp-errico-from-board-432SI-3092325

ROCKAWAY, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the 13th Annual LD Micro Invitational XIII in Los Angeles, California from June 6-8, 2023. LD Micro Invitational XIII: Date: Tuesday,

electroCore, Inc. (NASDAQ:NASDAQ:ECOR) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ETCompany ParticipantsNicole Jones - IRDan Goldberger - Chief Executive OfficerBrian Posner -…

electroCore (NASDAQ: ECOR ) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings electroCore missed estimated earnings by 24.0%, reporting an EPS of $-1.24 versus an … Full story available on Benzinga.com

Record first quarter 2023 net sales of $2.8 million, approximately 46% over first quarter 2022

A share of electroCore Inc. (NASDAQ:ECOR) closed at $0.26 per share on Friday, down from $0.29 day before. While electroCore Inc. has underperformed by -9.98%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ECOR fell by -57.21%, with highs and lows ranging from $0.98 to $0.19, […]

During the last session, electroCore Inc. (NASDAQ:ECOR)’s traded shares were 0.68 million, with the beta value of the company hitting 0.87. At the end of the trading day, the stock’s price was $0.26, reflecting an intraday loss of -9.98% or -$0.03. The 52-week high for the ECOR share is $0.98, that puts it down -276.92 … electroCore Inc. (NASDAQ: ECOR) Shares Have Been Down About -55.92% Year-To-Date Since The Beginning Of 2022 Read More »

electroCore (ECOR) launches a new wellness product offering called Truvaga for customers residing in the United States

ROCKAWAY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic company, today announced the launch of a new wellness product offering called TruvagaTM for customers residing in the United States. The new wellness product is offered through our new ecommerce site, www.truvaga.com, and promotes general wellbeing. Truvaga is a handheld

ROCKAWAY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic company, today announced the launch of a new wellness product offering called Truvaga TM for customers residing in the United States. The new wellness product is offered through our new ecommerce site, www.truvaga.com, and promotes general wellbeing.

ROCKAWAY, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore nVNS has been selected for further study under the United States Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) program. The program, which is expected to run through September 2023,

electroCore (ECOR) climbed 4% PM as 1Q22 revenue from product sales expected to be ~$1.9M vs consensus of $1.74M, an 27% increase Q/Q and 60% growth Y/Y. The Company expects to…

ElectroCore (ECOR) up 2% PM on agreement with a Japan based global conglomerate Teijin Limited to license certain exclusive rights to its non-invasive vagus nerve stimulation…

New York, USA, March 14, 2022 (GLOBE NEWSWIRE) -- Vagus Nerve Stimulators Market is Expected to Witness Positive Growth With A CAGR of 9.06% During the Study Period (2018-26) As per DelveInsight analysis, the Vagus Nerve Stimulators Market is witnessing a surge primarily due to the rising prevalence of neurological diseases, the increasing popularity of VNS therapy as an alternative or even conjunctive treatment in cases where drug resistance develops, growing research in studying the effects of VNS on other indications, technological advancements leading to the development of new products such as non-invasive Vagus Nerve Stimulation devices, and others. DelveInsight''s Vagus Nerve Stimulators Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Vagus Nerve Stimulators companies in the market. Key Takeaways from the Global Vagus Nerve Stimulators Market According to DelveInsight analysis, North America is anticipated to dominate the global Vagus Nerve Stimulators market during the forecast period.

During the last session, electroCore Inc. (NASDAQ:ECOR)’s traded shares were 0.37 million, with the beta value of the company hitting 0.93. At the end of the trading day, the stock’s price was $0.55, reflecting an intraday gain of 5.64% or $0.03. The 52-week high for the ECOR share is $2.44, that puts it down -343.64 … Boom Or Bust? Where Will electroCore Inc. (NASDAQ: ECOR) Stock Go Next? Read More »